期刊文献+

转化生长因子β_1与高血压及其靶器官损害的研究进展 被引量:6

Progress in the relationship on transforming growth factor-β_1 and hypertension and hypertensive target organ injury
下载PDF
导出
摘要 原发性高血压病是一种遗传和环境因素综合作用,引起的心血管系统,体液调节功能失调而致的血管平滑肌、心肌及细胞外基质(extracellular matrix,ECM)增生性疾病,常影响重要脏器如心、脑、肾的结构和功能。转化生长因子β1(TGF-β1)是一种调节细胞生长和分化及细胞外基质生成的多功能细胞因子。近来研究表明,TGF-β1及其介导的信号转导在高血压的发生、发展及转归中起着重要作用。现就TGF-β1在高血压及其靶器官的损害中作用的研究进展作一综述。 Hypertension is a proliferative disease of vascular smooth muscle,cardiac muscle and extracellular matrix(ECM) caused by humoral regulation dysfunction of cardiovascular system under the effect of heredity and environment,which does harm to vital organs such as the heart,brain and kidney.TGF-β1 is a kind of multifunction cytokines,stimulates cyto-production,participates in cells proliferation and influences extracellular matrix generation.Evidence illustated that TGF-β1 and its signal transduction play an immportant role in the initiation,progression and turnover of cardiovasculr disease.This review will summarize the progression in research on the role of hypertension and hypertensive target organ injury.
出处 《中国当代医药》 2010年第10期11-12,14,共3页 China Modern Medicine
关键词 转化生长因子 高血压 靶器官损害 TGF-β1 Hypertension Target organ damage
  • 相关文献

参考文献1

二级参考文献117

  • 1Devereux RB, Lyle PA. Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension (LIFE) study. Expert Opin Pharmacother 2004; 5:2311-2320.
  • 2Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest 1990; 85:507-514.
  • 3Rosenkranz S, Flesch M, Amann K, et al. Alterations of β- adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1. Am J Physiol Heart Circ Physiol2002; 283:H1253-1262.
  • 4Goumans M J, Zonneveld A J, ten Dijke E TGFβ-induced endothelial to mesenchymal transition; a switch to cardiac fibrosis? Trends Cardiovase Med, in press.
  • 5Larsson J, Goumans M J, Sjostrand L J, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-β type Ⅰ receptor-deficient mice. EMBO J 2001; 20:1663-1673.
  • 6Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333:918-924.
  • 7Heldin C-H, Miyazono K, ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390:465-471.
  • 8Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003; 113:685-700.
  • 9Schmierer B, Hill CS. TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol2007; 8:970-982.
  • 10ten Dijke P, Arthur HM. Extracellular control of TGFβ signalling in vascular development and disease. Nat Rev Mol Cell Biol2007; 8:857-869.

共引文献28

同被引文献78

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部